Actinic keratosis

Jump to: navigation, search
Actinic keratosis
Actinic keratosis 1.jpg
Actinic keratosis.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

WikiDoc Resources for Actinic keratosis


Most recent articles on Actinic keratosis

Most cited articles on Actinic keratosis

Review articles on Actinic keratosis

Articles on Actinic keratosis in N Eng J Med, Lancet, BMJ


Powerpoint slides on Actinic keratosis

Images of Actinic keratosis

Photos of Actinic keratosis

Podcasts & MP3s on Actinic keratosis

Videos on Actinic keratosis

Evidence Based Medicine

Cochrane Collaboration on Actinic keratosis

Bandolier on Actinic keratosis

TRIP on Actinic keratosis

Clinical Trials

Ongoing Trials on Actinic keratosis at Clinical

Trial results on Actinic keratosis

Clinical Trials on Actinic keratosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Actinic keratosis

NICE Guidance on Actinic keratosis


FDA on Actinic keratosis

CDC on Actinic keratosis


Books on Actinic keratosis


Actinic keratosis in the news

Be alerted to news on Actinic keratosis

News trends on Actinic keratosis


Blogs on Actinic keratosis


Definitions of Actinic keratosis

Patient Resources / Community

Patient resources on Actinic keratosis

Discussion groups on Actinic keratosis

Patient Handouts on Actinic keratosis

Directions to Hospitals Treating Actinic keratosis

Risk calculators and risk factors for Actinic keratosis

Healthcare Provider Resources

Symptoms of Actinic keratosis

Causes & Risk Factors for Actinic keratosis

Diagnostic studies for Actinic keratosis

Treatment of Actinic keratosis

Continuing Medical Education (CME)

CME Programs on Actinic keratosis


Actinic keratosis en Espanol

Actinic keratosis en Francais


Actinic keratosis in the Marketplace

Patents on Actinic keratosis

Experimental / Informatics

List of terms related to Actinic keratosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Synonyms and Keywords: Solar keratosis; AK


Actinic keratosis is a premalignant condition of thick, scaly, or crusty patches of skin. It is most common in fair-skinned people who are frequently exposed to the sun, because their pigment isn't very protective. It usually is accompanied by solar damage. Since some of these pre-cancers progress to squamous cell carcinoma, they should be treated.


When skin is exposed to the sun constantly, thick, scaly, or crusty bumps appear. The scaly or crusty part of the bump is dry and rough. The growths start out as flat scaly areas, and later grow into a tough, wart-like area.


Physical Examination

An actinic keratosis site commonly ranges in between 2 to 6 millimeters, and can be dark or light, tan, pink, red, a combination of all these, or the same pigment of one's skin. It may appear on any sun-exposed area, such as the face, ears, neck, scalp, chest, back of hands, forearms, lips etc.



Other Diagnostic Studies

Doctors can usually identify AK by doing a thorough examination. A biopsy may be necessary when the keratosis is large and/or thick, to make sure that the bump is a keratosis and not a skin cancer. Seborrheic keratoses are other bumps that appear in groups like the actinic keratosis but are not caused by sun exposure, and are not related to skin cancers. Seborrheic keratoses may be mistaken for an actinic keratosis.


Medical Therapy

Various modalities are employed in the treatment of actinic keratosis:


Regular follow-up after treatment is advised by many doctors. The regular checks are to make sure new bumps have not developed and that old ones haven't become thicker and/or have skin disease.

Primary Prevention

Preventative measures recommended for AK are similar to those for skin cancer:

  • Not staying in the sun for long periods of time without protection (e.g.sunscreen, clothing, hats).
  • Frequently applying powerful sunscreens with SPF ratings greater than 15 and that also block both UVA andUVB light.
  • Using sunscreen even in winter sun exposure.
  • Wearing sun protective clothing such as hats, long-sleeved shirts, long skirts, or pants.
  • Avoiding sun exposure during noon hours is very helpful because ultraviolet light is the most powerful at that time.

Future or Investigational Therapies

As of 2008 a company in Australia named Clinuvel Pharmaceuticals Limited is performing clinical trials with a melanocyte-stimulating hormone named melanotan (which they refer to as CUV1647) for actinic keratosis in organ transplant patients.[2]


  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 "Dermatology Atlas".
  2. Clinuvel » Investors » FAQs